FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileAdvisorShares Psychedelics ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
PSIL
AdvisorShares Psychedelics ETF ETF AnalysisComprehensive ETF analysis for AdvisorShares Psychedelics ETF (PSIL) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisPSIL
PSIL
AdvisorShares Psychedelics ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
PSIL
  1. Home
  2. Screener
  3. AdvisorShares Psychedelics ETFPSILETF
AdvisorShares Psychedelics ETF Logo

AdvisorShares Psychedelics ETF

ETF
🇺🇸PSIL•AMEX•Equity

Your view on PSIL

AdvisorShares Psychedelics ETF Logo

AdvisorShares Psychedelics ETF

ETFAdvisorShares
🇺🇸PSIL•AMEX•Equity
AUM (USD)$41.60M
Expense Ratio1.28%
Yield (TTM)9.63%
Holdings25

Sentiment

—

AUM (USD)

$41.60M

Expense Ratio

1.28%

Yield (TTM)

9.63%

Holdings

25

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

AdvisorShares Psychedelics ETF (PSIL) is an Equity fund from AdvisorShares, listed since 2021, with $41.6M in assets under management, a 1.28% expense ratio and a NAV of $19.30 USD.

Overview for AdvisorShares Psychedelics ETF

Fund Type
ETF
Fund Issuer
AdvisorShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
September 15, 2021
Domicile
US
Website
advisorshares.com/etfs/PSIL
Fund Type
ETF
Fund Issuer
AdvisorShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
September 15, 2021
Domicile
US
Website
advisorshares.com/etfs/PSIL
Fund Type
ETF
Fund Issuer
AdvisorShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
September 15, 2021
Domicile
US
Website
advisorshares.com/etfs/PSIL

About this fund

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from …

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

1.28%

Yield (TTM)

9.63%

AUM

$41.60M

Fund Details

NAV$19.30 USD
Holdings25
Average Volume33.8K
Inception DateSeptember 15, 2021
Asset ClassEquity
Fund IssuerAdvisorShares
DomicileUS
ISINUS00768Y2972
CUSIP00768Y297
NAV CurrencyUSD

Expense Ratio

1.28%

Dividend Yield (TTM)

9.63%

Assets Under Management

$41.60M

NAV

$19.30 USD

Holdings

25

Average Volume

33.8K

Inception Date

September 15, 2021

Asset Class

Equity

Fund Issuer

AdvisorShares

Domicile

US

ISIN

US00768Y2972

CUSIP

00768Y297

NAV Currency

USD

Expense Ratio

1.28%

Dividend Yield (TTM)

9.63%

Assets Under Management

$41.60M

NAV

$19.30 USD

Holdings

25

Average Volume

33.8K

Inception Date

September 15, 2021

Asset Class

Equity

Fund Issuer

AdvisorShares

Domicile

US

ISIN

US00768Y2972

CUSIP

00768Y297

NAV Currency

USD

Distributions · last 12 months

Quarterly · 1 payment

Ex-datePaidAmount
Dec 22, 2025Dec 29, 2025$1.6839
Total, 12 months$1.68 a share

Dividend yield (TTM) 9.63% = $1.68 paid per share in the 12 months to Nov 19, 2026 ÷ the $17.49 price. Past distributions; future payments can differ.

Data last updated: Nov 16, 2026, 08:11 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

29 positions
1DFTXDEFINIUM THERAPEUTICS INC
11.76%
2CMPSCOMPASS PATHWAYS PLC
10.59%
3HELPHELUS PHARMA INC
7.13%
4LLYELI LILLY & CO
6.78%
5NBIXNEUROCRINE BIOSCIENCES INC
6.42%
6ABBVABBVIE INC
6.09%
7SUPNSUPERNUS INC
5.45%
8SPTXSEAPORT THERAPEUTICS INC
5.28%
9NRXPNRX PHARMACEUTICALS INC
5.18%
10RLMDRELMADA THERAPEUTICS INC
4.99%
11JNJJOHNSON & JOHNSON
4.92%
12GHRSGH RESEARCH PLC
4.91%
13ANROALTO NEUROSCIENCE INC
4.64%
14STIMNEURONETICS INC
3.62%
15DRUGBRIGHT MINDS BIOSCIENCES INC
2.64%

Concentration

Total Holdings29
Top 10 Weight69.66%
Top HoldingDFTX
Top Weight11.76%
1DFTXDEFINIUM THERAPEUTICS INC
11.76%
2CMPSCOMPASS PATHWAYS PLC
10.59%
3HELPHELUS PHARMA INC
7.13%
4LLYELI LILLY & CO
6.78%
5NBIXNEUROCRINE BIOSCIENCES INC
6.42%
6ABBVABBVIE INC
6.09%
7SUPNSUPERNUS INC
5.45%
8SPTXSEAPORT THERAPEUTICS INC
5.28%
9NRXPNRX PHARMACEUTICALS INC
5.18%
10RLMDRELMADA THERAPEUTICS INC
4.99%
11JNJJOHNSON & JOHNSON
4.92%
12GHRSGH RESEARCH PLC
4.91%
13ANROALTO NEUROSCIENCE INC
4.64%
14STIMNEURONETICS INC
3.62%
15DRUGBRIGHT MINDS BIOSCIENCES INC
2.64%

Total Holdings

29

Top 10 Weight

69.66%

Top Holding

DFTX

Top Weight

11.76%

1DFTXDEFINIUM THERAPEUTICS INC
11.76%$4.46M
2CMPSCOMPASS PATHWAYS PLC
10.59%$4.01M
3HELPHELUS PHARMA INC
7.13%$2.70M
4LLYELI LILLY & CO
6.78%$2.57M
5NBIXNEUROCRINE BIOSCIENCES INC
6.42%$2.44M
6ABBVABBVIE INC
6.09%$2.31M
7SUPNSUPERNUS INC
5.45%$2.07M
8SPTXSEAPORT THERAPEUTICS INC
5.28%$2.00M
9NRXPNRX PHARMACEUTICALS INC
5.18%$1.96M
10RLMDRELMADA THERAPEUTICS INC
4.99%$1.89M
11JNJJOHNSON & JOHNSON
4.92%$1.87M
12GHRSGH RESEARCH PLC
4.91%$1.86M
13ANROALTO NEUROSCIENCE INC
4.64%$1.76M
14STIMNEURONETICS INC
3.62%$1.37M
15DRUGBRIGHT MINDS BIOSCIENCES INC
2.64%$1.00M

Total Holdings

29

Top 10 Weight

69.66%

Top Holding

DFTX

Top Weight

11.76%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on19 funds
FundAsset classExpense ratioAssetsHoldings
PSILAdvisorShares Psychedelics ETFThis fundEquity1.28%$42M25

Comparable funds

  • APRZTrueShares Structured Outcome (April) ETFEquity0.79%$33M14
  • ARMGLeverage Shares 2x Long ARM Daily ETFEquity0.75%$41M5
  • BOEUDirexion Daily BA Bull 2X SharesEquity1.30%$23M6
  • DUKQOcean Park Domestic ETFEquity2.06%$10M0
  • GUMIGoldman Sachs Ultra Short Municipal Income ETFFixed Income0.16%$103M221
  • MULTFranklin Multisector Income ETFFixed Income0.39%$10M0
  • PSFOPacer Swan SOS Flex (October) ETFEquity0.49%$49M7

More AdvisorShares ETFs

  • MSOSAdvisorShares Pure US Cannabis ETFEquity0.75%$793M28
  • MSOXAdvisorShares MSOS Daily Leveraged ETFLeveraged/Inverse1.20%$46M6
  • QPXAdvisorShares Q Dynamic Growth ETFEquity1.86%$32M9
  • SUREAdvisorShares Insider Advantage ETFEquity0.98%$58M101
  • VEGASTAR GLOBAL BUY-WRITE ETFEquity1.23%$94M13
  • YOLOAdvisorShares Pure Cannabis ETFEquity1.45%$30M25
  • AADRDORSEY WRIGHT ADR ETFEquity1.10%$34M37
  • CWSAdvisorShares Focused Equity ETFEquity0.78%$111M27
  • DWAWAdvisorShares Dorsey Wright FSM All Cap World Equity ETFEquity1.19%$88M4
  • DWSHAdvisorShares Dorsey Wright Short ETFLeveraged/Inverse4.07%$6M102
  • DWUSAdvisorShares Dorsey Wright FSM U.S. Core ETFEquity1.11%$116M4
  • GKAdvisorShares Gerber Kawasaki ETFEquity1.27%$29M32
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News